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Dear Editor,
This letter is a comment on the paper by Adali et al. [1] enti-
tled BThe Relationship Between Histopathologic Findings and
Body Mass Index in Sleeve Gastrectomy Materials^.
In terms of novelty, in the first page of their article, the
authors firmly assert Bthere is no previous study investigating
the relationship between gastric histopathological findings
and BMI in sleeve gastrectomy patients^ [1]. In their discus-
sion section, they decisively affirm Bno studies have been
conducted to show the relationship between BMI and histo-
pathological findings until now and this is the first study in the
literature to note this correlation^ [1]. Finally in their conclud-
ing page, they confirm that their study Bis the first to evaluate
the relationship between BMI and histopathological findings^
[1]. All these statements seem grossly inaccurate and entirley
invalid.
In an article published in the same journal some 15 months
earlier, others [2] had already clearly assessed and reported the
associations between BMI and different histopathological
changes in sleeve gastrectomy (SG) specimens. Specifically,
Saafan et al. [2] evaluated the relationship between BMI and
follicular gastritis, lymphoid aggregates, GIST, intestinal
metaplasia, and chronic active gastritis. Given that Adali
et al. [1], in their introduction section, did not highlight the
gap in the literature that their research addresses, hence, it is
not entirely clear whether they were aware of the work of
others [2] in this respect that was published more than a year
prior to their article [1], and addressed the gap in knowledge
on the relationship between BMI and gastric histopathological
findings among SG specimens [2].
In terms of findings, Saafan et al. [2] reported non-
significant relationships between BMI and the different histo-
pathologies. Comparisons between cases of follicular gastritis
and lymphoid aggregate specimens collectively (precursors of
MALT) vs. normal SG specimens (controls) revealed no BMI
differences [2]. Follicular gastritis was present in the speci-
mens of the more obese patients as compared with lymphoid
aggregates, but the differences were not significant [2].
Likewise, comparisons between patients with GIST or intesti-
nal metaplasia (precursors of gastric adenocarcinoma) vs. nor-
mal specimens did not uncover significant BMI differences,
and equally, comparisons between patients with chronic active
gastritis vs. normal specimens (controls) did not disclose sig-
nificant BMI differences [2]. In agreement with Saafan et al.
[2], Adali et al. [1] found no statistically significant relation-
ship between BMI and type/severity of gastritis, presence/
severity of lymphoid follicle, or of lymphoid aggregate.
However, in contrast with Saafan et al. [2], they [1] reported
significant association between BMI and intestinal metaplasia.
Interestingly, Adali et al. [1] cited Saafan et al. [2] in their
article, and enumerated in their discussion section [1] the
types of histopathologies reported by Saafan et al. [2]. Such
detail highly suggests that Adali et al. [1] were completely
aware of Saafan et al.’s [2] findings. However, Adali et al.
[1] sufficed to enumerate the types of histopathologies report-
ed by Saafan et al. [2], but certainly and selectively opted not
to refer in any way to any of Saafan et al.’s [2] BMI findings,
despite that their paper’s title [1] suggests that BMI comprised
the main thrust of their study.
The differences in Saafan et al.’s [2] findings compared to
Adali et al. [1] might be attributed to sample size and/or study
design among other factors. In terms of sample size, they
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examined much fewer cases, which they acknowledge as Ba
limitation due to the low number of the cases^, where for
many pathologies the groups ranged from 3 to 34 specimens
[1]. Saafan et al. [2], on the other hand, compared groups with
different pathologies that ranged from 11 to 109 cases or
controls.
In terms of study design, Saafan et al. [2] employed Btrue^
controls (i.e., normal SG specimens) as the comparison group
that was compared with cases of given pathology/ies. In con-
trast, Adali et al. [1] seem not have used such controls with
normal SG specimens. Rather, they [1] compared the findings
of patients with any given pathology to the rest of their sample
(that did not have the given pathology but had other patholo-
gy/ies). Such lack of Bnormal^ controls as a comparison group
might have influenced their reported findings.
The inclusion of normal controls or lack thereof might be a
function of the question that is under examination. If the ques-
tion is BAre their BMI differences between patients with pa-
thologies compared to those with no pathologies in SG
specimens?^, then a control group with normal specimens
would be appropriate. Alternatively, if the question asks
BAre their BMI differences between patients with a given
pathology compared to patients with other pathology/ies in
SG specimens?^, then perhaps a control group with other
pathology/ies might suffice.
Adali et al. [1] aimed to Binvestigate the relationship be-
tween the BMI of patients and histopathologic findings of SG
materials sent to the pathology laboratory for routine
examination^. To the best of our understanding, this does
not explicitly inform the reader as to which of the above two
questions they were tackling, or if any other. Hence, it is not
feasible to appraise the appropriateness of their comparison
group. However, the published literature suggests that normal
specimens constitute almost half if not more of the total spec-
imens in laparoscopic SG patients [2–6]. Thus, it might be
reasonable to conclude that Adali et al. [1] were not short of
normal controls as a comparison group. As in all studies with
control group/s, the appropriateness of the control group/s to
the question examined is a critical issue, and will influence
and determine the validity of the subsequent findings and
hence the quality of the evidence generated and authority of
a given study.
The relationships between histopathologic findings and
BMI in SG specimens are important and remain to be assessed
and reported. Should it emerge, beyond reasonable doubt, that
there exists significant associations between BMI and precur-
sors of malignancies as identified histopathologically in SG
materials, e.g., follicular gastritis and lymphoid aggregates
(both can be predecessors of gastric MALT lymphoma [7]);
or between BMI and benign tumor with potential for malig-
nancy (e.g., GIST) [8]; or between BMI and precursors for
gastric adenocarcinoma (e.g., intestinal metaplasia [9]), then
such findings would probably influence research, affect prac-
tice, and impact on the risk information provided to obese
individuals and patients.
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